Sign in
4/A

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-19-000065

Director sold 62,925 shares at $29.70 ($1,869,168)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-12-18 Sale : show line 1 in the form −62,925 $29.70 $1,869,168 1,171,268 I
Open-market sales · 62,925 sh · avg $29.70 · $1,869,168
Loading xslF345X03/crisprfm4a_dec192018.xml…